153 related articles for article (PubMed ID: 7695406)
1. Characteristics of nine newly derived mesothelioma cell lines.
Pass HI; Stevens EJ; Oie H; Tsokos MG; Abati AD; Fetsch PA; Mew DJ; Pogrebniak HW; Matthews WJ
Ann Thorac Surg; 1995 Apr; 59(4):835-44. PubMed ID: 7695406
[TBL] [Abstract][Full Text] [Related]
2. Phenotypes and karyotypes of human malignant mesothelioma cell lines.
Relan V; Morrison L; Parsonson K; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Fong KM; Bowman RV
PLoS One; 2013; 8(3):e58132. PubMed ID: 23516439
[TBL] [Abstract][Full Text] [Related]
3. Characterization of three human malignant mesothelioma cell lines.
Versnel MA; Hoogsteden HC; Hagemeijer A; Bouts MJ; van der Kwast TH; Delahaye M; Schaart G; Ramaekers FC
Cancer Genet Cytogenet; 1989 Oct; 42(1):115-28. PubMed ID: 2790740
[TBL] [Abstract][Full Text] [Related]
4. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.
Pelin-Enlund K; Husgafvel-Pursiainen K; Tammilehto L; Klockars M; Jantunen K; Gerwin BI; Harris CC; Tuomi T; Vanhala E; Mattson K
Carcinogenesis; 1990 Apr; 11(4):673-81. PubMed ID: 2323006
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.
Manning LS; Whitaker D; Murch AR; Garlepp MJ; Davis MR; Musk AW; Robinson BW
Int J Cancer; 1991 Jan; 47(2):285-90. PubMed ID: 1703129
[TBL] [Abstract][Full Text] [Related]
6. Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis.
Orengo AM; Spoletini L; Procopio A; Favoni RE; De Cupis A; Ardizzoni A; Castagneto B; Ribotta M; Betta PG; Ferrini S; Mutti L
Eur Respir J; 1999 Mar; 13(3):527-34. PubMed ID: 10232421
[TBL] [Abstract][Full Text] [Related]
7. High CD44 expression on human mesotheliomas mediates association with hyaluronan.
Penno MB; Askin FB; Ma H; Carbone M; Vargas MP; Pass HI
Cancer J Sci Am; 1995; 1(3):196-203. PubMed ID: 9166476
[TBL] [Abstract][Full Text] [Related]
8. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines.
Klominek J; Robért KH; Hjerpe A; Wickström B; Gahrton G
Cancer Res; 1989 Nov; 49(21):6118-22. PubMed ID: 2790824
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature.
Schmitter D; Lauber B; Fagg B; Stahel RA
Int J Cancer; 1992 May; 51(2):296-301. PubMed ID: 1373705
[TBL] [Abstract][Full Text] [Related]
10. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
Kobayashi M; Takeuchi T; Ohtsuki Y
Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
[TBL] [Abstract][Full Text] [Related]
11. Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features. Comparative genomic hybridization evidence for a mesothelioma subgroup.
Krismann M; Müller KM; Jaworska M; Johnen G
J Mol Diagn; 2000 Nov; 2(4):209-16. PubMed ID: 11232111
[TBL] [Abstract][Full Text] [Related]
12. Autocrine inhibitory influences of alpha-melanocyte-stimulating hormone in malignant pleural mesothelioma.
Catania A; Colombo G; Carlin A; Garofalo L; Gatti S; Buffa R; Carboni N; Rosso L; Santambrogio L; Cantalamessa L; Lipton JM
J Leukoc Biol; 2004 Feb; 75(2):253-9. PubMed ID: 14576363
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies of mesothelioma.
Pass HI; Mew DJ
J Cell Biochem Suppl; 1996; 24():142-51. PubMed ID: 8806096
[TBL] [Abstract][Full Text] [Related]
14. [Clonal chromosome abnormalities in a case of pleural mesothelioma].
Pegoraro M; Bersi M; Gasparini C; Cardini G; Ruffoni A
Arch Sci Med (Torino); 1973; 130(2):125-30. PubMed ID: 17342920
[TBL] [Abstract][Full Text] [Related]
15. Spindle cell tumours of the pleura: a clinical, histological and comparative genomic hybridization analysis of 14 cases.
Knuuttila A; Jee KJ; Taskinen E; Wolff H; Knuutila S; Anttila S
Virchows Arch; 2006 Feb; 448(2):135-41. PubMed ID: 16170537
[TBL] [Abstract][Full Text] [Related]
16. Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.
Philippeaux MM; Pache JC; Dahoun S; Barnet M; Robert JH; Mauël J; Spiliopoulos A
Histochem Cell Biol; 2004 Sep; 122(3):249-60. PubMed ID: 15372243
[TBL] [Abstract][Full Text] [Related]
17. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
[TBL] [Abstract][Full Text] [Related]
18. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
Uematsu K; Kanazawa S; You L; He B; Xu Z; Li K; Peterlin BM; McCormick F; Jablons DM
Cancer Res; 2003 Aug; 63(15):4547-51. PubMed ID: 12907630
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal alterations in early stages of malignant mesotheliomas.
Simon F; Johnen G; Krismann M; Müller KM
Virchows Arch; 2005 Oct; 447(4):762-7. PubMed ID: 16012846
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of a localized malignant mesothelioma.
Gómez-Román JJ; Mons-Lera R; Olmedo IS; Val-Bernal JF
Ann Thorac Surg; 2002 Apr; 73(4):1292-4. PubMed ID: 11996274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
